As many as 8 to 10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Hum… https://t.co/2EMUtSMzOv

‘Biosimilars’ Were Supposed to Tame Costs for Drugs Like Humira. It Isn’t Working. https://t.co/vUOUXdRvC6 via… https://t.co/IyHVdoDknS

There’s no cure for plaque psoriasis, but there are ways to manage it and treat its symptoms.

Sponsored by @IBX https://t.co/jvBLFmLkes

Exploring Biosimilars as a Drug Patent Strategy https://t.co/O2enCAcvRw #patent #business https://t.co/67cz0Gl6ly

Biosimilars are Here and More Options are On the Horizon!
Check out this new #CME curriculum!
View here:… https://t.co/6WMrrmYHoP

New #HumiraBiosimilars that launch this year will eventually increase #patientaccess to treatment and generate… https://t.co/Vj3q3fpjmt

A study shows that the #tocilizumab biosimilar, MSB11456, has similar pharmacokinetics and safety profiles as the r… https://t.co/z3ooBJDo8x

A study shows that the #tocilizumab biosimilar, MSB11456, has similar pharmacokinetics and safety profiles as the r… https://t.co/5DjDK5Quvf